Innoviva Inc
INVAHealthcare|Biotechnology|USA
$22.23
+0.04 (+0.20%)
DCF (FCF)
$42.29
Tangible Book
$15.56
Graham Number
$41.06
Earnings Power
$26.78
Clinical Trials (6)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06794541 A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI) | Complicated Intra-abdominal Infections (cIAI) | P2 | Recruiting | 35 | Open-label | IV Eravacycline 2mg/kg, IV Eravacycline 1.5mg/kg |
| NCT06801223 A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection | Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) | P1 | Recruiting | 48 | Open-label | Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours), Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours), Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours) |
| NCT06746883 A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection | Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) | Recruiting | 100 | — | — | |
| NCT07568275 Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance | Septic Shock, Cirrhosis | Early P1 | Active | 30 | RCT, Open-label | Giapreza |
| NCT07212686 Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension | Vasodilatory Shock | P4 | By Invite | 30 | Open-label | Angiotensin-II |
| NCT07485010 Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial | Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection | P2 | Not Yet Recruiting | 300 | RCT, Open-label | Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin, Azithromcyin, clarithromycin, Clofazimine, Ethambutol, Amikacin Injection, tigecycline, Imipenem + Cilastatin, Cefoxitin, Amikacin (Inhalation), linezolid, Trimethoprim / Sulfamethoxazole, Doxycycline, moxifloxacin, bedaquiline, Rifabutin |